Skip to main content

Advertisement

Table 16 Anticancer activity results of most active compound b2

From: Therapeutic potential of heterocyclic pyrimidine scaffolds

Compound CNS cancer cell lines 10−5 M concentration Ovarian cancer cell lines 10−5 M concentration
b2 SF-268 2.95 IGROV1 7.71
SF-295 9.79 OVCAR-3 6.34
SF-539 3.99 OVCAR-4 3.42
SNB-19 5.42 OVCAR-8 4.92
SNB-57 2.49
U-251 3.58